title: Does transthyretin function as one of contributors for preeclampsia?
abstract: Preeclampsia (PE) is a multi-system disorder of pregnancy, which is characterized by new onset hypertension and proteinuria, resulting in multi-organ damages within a potential procedure. However as a worldwide leading cause of maternal and fetal mortality and morbidity, the precise origin of PE has not been clarified yet, which also makes obstacles to the management of the disease. Transthyretin (TTR) is a special protein involved in amyloid diseases, has important effects on amyloid fibrils formation. We assumed that TTR might cause a disorder of maternal vascular function and contributed to the pathology of the disease by deposition of TTR amyloid fibrils in the vascular system, which are produced by variant TTR proteins, resulting in organ ischemia. If this hypothesis proves to be correct, this variant may be of diagnostic importance as novel biomarkers for the disease, in addition, it might also benefit to the management of PE.
authors.affiliation: Beijing Chaoyang Hospital affiliated Capital Medical University, Department of Obstetrics and Gynecology, Beijing, China.
authors.forename: Yuxuan
authors.initials: Y
authors.lastname: Chen
authors.forename: Zhenyu
authors.initials: Z
authors.lastname: Zhang
mesh_terms: D005260:Female; D006801:Humans; D011225:Pre-Eclampsia / Q000503:physiopathology*; D011228:Prealbumin / Q000502:physiology*; D011247:Pregnancy; D012307:Risk Factors
chemical_list: D011228:Prealbumin
references.citation: J Med Chem. 2009 Feb 26;52(4):1115-25
references.pmid: 19191553
references.citation: Am J Hum Genet. 1990 Jul;47(1):127-36
references.pmid: 2349941
references.citation: PLoS One. 2009;4(1):e4124
references.pmid: 19125186
references.citation: J Proteome Res. 2007 Jan;6(1):160-70
references.pmid: 17203960
references.citation: Clin Biochem Rev. 2006 May;27(2):99-116
references.pmid: 17077880
references.citation: Thyroid. 2000 Feb;10(2):141-9
references.pmid: 10718550
references.citation: J Med Chem. 2008 Oct 23;51(20):6348-58
references.pmid: 18811132
references.citation: J Clin Pathol. 2005 Feb;58(2):125-33
references.pmid: 15677530
references.citation: Mol Cell Proteomics. 2008 Aug;7(8):1570-83
references.pmid: 18474516
references.citation: Heart. 2005 Feb;91(2):257-64
references.pmid: 15657260
references.citation: Biochem J. 2004 Jul 15;381(Pt 2):351-6
references.pmid: 15080795
references.citation: Reprod Biol Endocrinol. 2009 Jul 14;7:70
references.pmid: 19602262
references.citation: Eur J Hum Genet. 2010 Aug;18(8):948-52
references.pmid: 20234390
references.citation: Reprod Biomed Online. 2005 May;10(5):641-4
references.pmid: 15949223
references.citation: Biochemistry. 2005 Dec 20;44(50):16612-23
references.pmid: 16342952
references.citation: J Proteomics. 2009 Jul 21;72(5):731-9
references.pmid: 19332162
references.citation: Proteome Sci. 2004 Sep 1;2(1):5
references.pmid: 15341658
references.citation: Virchows Arch. 2010 May;456(5):523-32
references.pmid: 20376481
references.citation: J Neurol Sci. 2008 Sep 15;272(1-2):186-90
references.pmid: 18579156
references.citation: J Clin Endocrinol Metab. 2005 Dec;90(12):6714-20
references.pmid: 16159939
references.citation: Hum Mutat. 2001 Jun;17(6):493-503
references.pmid: 11385707
references.citation: Biomark Insights. 2007 Aug 08;2:299-306
references.pmid: 19662213
references.citation: Am J Obstet Gynecol. 1999 Feb;180(2 Pt 1):499-506
references.pmid: 9988826
references.citation: J Zhejiang Univ Sci B. 2005 Nov;6(11):1045-56
references.pmid: 16252337
references.citation: Expert Rev Cardiovasc Ther. 2008 Nov;6(10):1367-77
references.pmid: 19018690
references.citation: Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2817-22
references.pmid: 14981241
references.citation: Mol Med. 2007 Nov-Dec;13(11-12):584-91
references.pmid: 17932549
references.citation: Hypertens Pregnancy. 2010 Jan;29(2):206-30
references.pmid: 20102284